Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea
Authors
Keywords
-
Journal
CNS DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-17
DOI
10.1007/s40263-023-01040-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Solriamfetol real world experience study (SURWEY): Initiation, titration, safety, effectiveness, and experience during follow-up for patients with narcolepsy from Germany
- (2023) Yaroslav Winter et al. SLEEP MEDICINE
- Comparative Efficacy and Safety of Wakefulness-Promoting Agents for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea
- (2023) Tyler Pitre et al. ANNALS OF INTERNAL MEDICINE
- Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Excessive Daytime Sleepiness in Narcolepsy: A Network Meta-Analysis
- (2023) Shuqin Zhan et al. Nature and Science of Sleep
- Effects of solriamfetol treatment on body weight in participants with obstructive sleep apnea or narcolepsy
- (2022) Atul Malhotra et al. SLEEP MEDICINE
- Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression
- (2022) Andrew D. Krystal et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Understanding and approaching excessive daytime sleepiness
- (2022) Laura Pérez-Carbonell et al. LANCET
- Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis
- (2022) Po-Yu Chien et al. Journal of Clinical Medicine
- Pharmacologic Management of Excessive Daytime Sleepiness
- (2022) Taisuke Ono et al. Sleep Medicine Clinics
- Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in Obstructive Sleep Apnea: An Analysis of Subgroups Adherent or Nonadherent to Obstructive Sleep Apnea Treatment
- (2021) Paula K. Schweitzer et al. CHEST
- Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline
- (2021) Kiran Maski et al. Journal of Clinical Sleep Medicine
- Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea
- (2021) Terri E. Weaver et al. Journal of Clinical Sleep Medicine
- Excessive Daytime Sleepiness
- (2021) Kriti D. Gandhi et al. MAYO CLINIC PROCEEDINGS
- European guideline and expert statements on the management of narcolepsy in adults and children
- (2021) Claudio L. A. Bassetti et al. EUROPEAN JOURNAL OF NEUROLOGY
- Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea
- (2021) Sarah Ronnebaum et al. Journal of Clinical Sleep Medicine
- Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management
- (2021) Russell Rosenberg et al. POSTGRADUATE MEDICINE
- European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea
- (2021) Winfried Randerath et al. European Respiratory Review
- Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial
- (2020) Yves Dauvilliers et al. CNS DRUGS
- A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants
- (2020) Katie Zomorodi et al. Clinical Pharmacology in Drug Development
- Effects of solriamfetol in a long-term trial of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy
- (2020) Paula K. Schweitzer et al. Journal of Clinical Sleep Medicine
- Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis
- (2019) Katie Zomorodi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A randomized study of solriamfetol for excessive sleepiness in narcolepsy
- (2019) Michael J. Thorpy et al. ANNALS OF NEUROLOGY
- Solriamfetol: First Global Approval
- (2019) Anthony Markham DRUGS
- Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
- (2019) Atul Malhotra et al. SLEEP
- Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy
- (2019) Helene A. Emsellem et al. SLEEP MEDICINE
- Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
- (2018) Michelle G. Baladi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3): A Randomized Controlled Trial
- (2018) Paula K. Schweitzer et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Solriamfetol for the Treatment of Excessive Sleepiness in OSA
- (2018) Patrick J. Strollo et al. CHEST
- A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
- (2018) Lawrence P Carter et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
- (2016) Chad Ruoff et al. SLEEP
- Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
- (2016) Chad Ruoff et al. SLEEP
- Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy
- (2015) Richard K. Bogan et al. SLEEP MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now